AUY922
Drug timelines are a Plus or Pro feature.
17 regulatory and trial events tracked for AUY922, covering 2013-02-07 to 2020-12-17. Get the full timeline:
Most recent: Clinical Trial Update: Phase I-II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 in Advanced Solid Malignancies, and Efficacy in HER2+ or ER+ Locally Advanced or Metastatic Breast Cancer Patients [Phase 1, Phase 2]